In 2022, Emily was the 202nd person world-wide to be diagnosed with DYRK1A syndrome.

DYRK1A syndrome is the result of a mutation of the DYRK1A gene which is found on the 21st chromosome. People with the syndrome have intellectual disability, epilepsy, autism, microcephaly (small head), severe speech impairment, and feeding difficulties.

Early and intensive therapeutic intervention plays an important role in helping people with DYRK1A syndrome maximize their potential and live their best lives. 

For more information, visit http://www.dyrk1a.org.